Introduction
============

Effective control and modulation of cellular behavior is of paramount importance in medicine ([@b28]) and biotechnology ([@b19]), and requires profound understanding of control mechanisms. In cancer treatment, for example, it would be of great impact to induce apoptosis only in tumor cells but not in healthy ones, while in biotechnology it is important for the cost-effectiveness of a process to minimize the formation of by-products and redirect carbon toward desired compound(s). Learning the mechanisms through which cells regulate their response to changing environments can help in the design of reverse-engineering regulatory circuits to modulate cellular behavior ([@b8]). To date, regulatory mechanisms are mostly inferred from gene expression, interaction or binding data ([@b35]; [@b26]; [@b43]). Yet, the ability to predict cellular behavior from such inferred mechanisms is still poor ([@b3]), owing to the fact that many regulatory events remain hidden. In particular, very little is known about how changes in transcript and protein levels affect metabolic readjustment, and thus, phenotypic behavior ([@b21]).

Transcriptional regulation is arguably at the forefront of a cells\'s ability to control resource availability, being the first regulatory layer to determine new cellular composition. Over the last decade, transcriptional regulatory networks have been extensively investigated, and the backbone of potential 'transcription factor--target gene\' interactions has been reconstructed based on genome-wide protein-DNA binding analysis and high-throughput gene expression data ([@b3]). The first large-scale protein--DNA binding analysis study of the model eukaryote *Saccharomyces cerevisiae* revealed a highly connected transcription factor network architecture ([@b30]), whose condition-dependent interaction connectivity was later identified based on protein--DNA binding data from different stress conditions ([@b17]). Large-scale genome-wide expression data were used to reconstruct the organization of transcription factor networks by graph theory ([@b54]; [@b23]), probabilistic graphical models ([@b41]) or clustering algorithms ([@b24]). The integration of protein--DNA binding topology and gene expression data through statistical approaches was used to reconstruct the architecture of the responsive transcriptional regulatory network, unraveling a rewiring of the transcriptional network interactions in response to various stimuli ([@b32]; [@b1]; [@b15]). An even higher level of integration was achieved by combining protein--DNA binding profiles with genetic perturbations, gene expression data, protein interaction data and systematic phenotyping to reveal causal pathway models that provide global hypotheses of how signaling and transcription are linked ([@b53]). Despite this extensive knowledge, the link from transcriptional regulation to the functional output is largely missing, because changes in transcript/protein abundance do not necessarily lead to equal (or any) changes in function. Explicitly, if the condition-dependent binding of a transcription factor leads to differential expression of its target gene(s), the consequences of such regulation on cellular operation remains nearly impossible to predict.

In this study, we aim to elucidate the extent to which transcription factors control the operation of yeast metabolism. As a quantitative readout of metabolic function, we monitored the traffic of small molecules through various pathways of central metabolism by ^13^C-flux analysis ([@b39]). For a systematic analysis, we quantified the flux distributions (pathway activities) within central carbon metabolism of 119 single deletion strains that lack metabolism-related transcription factors under five different growth conditions. We identified condition-dependent networks of transcription factors that control metabolic pathway activity ([Figure 1](#f1){ref-type="fig"}). Despite their widespread impact on gene expression ([@b23]), only very few transcription factors affect pathway activity and thus the flux distributions. For transcription factors that affect the flux distribution, we then unraveled flux relevant enzymes based on consistent changes in protein abundances, and further hypothesize on the underlying mechanism leading to the control of metabolic flux distributions based on genome-wide gene expression data ([Figure 1](#f1){ref-type="fig"}).

Results
=======

In the yeast *S. cerevisiae*, 275 genes are annotated as 'transcriptional regulatory active\' in the yeast genome database ([@b6]). Out of these, we selected 119 transcription factors related to metabolism or stress responses, covering ∼70% of all transcription factors with target genes in at least one of the two processes. For each of these 119 transcription factors, prototrophic deletion strains were constructed and grown under five conditions: glucose, glucose with high osmolarity, glucose with urea as nitrogen source, glucose with low pH and galactose ([Supplementary Table 1](#S1){ref-type="supplementary-material"}). The chosen growth conditions suit the requirements for flux analysis, such as exponential growth on minimal medium ([@b56]). They represent two different regulatory states of reduced (galactose) and maximal carbon source repression (glucose), as well as a different nitrogen metabolism and two common, permanent stress conditions.

As a general measure for effects of the deleted transcription factors on metabolism, we determined growth rates ([Figure 2](#f2){ref-type="fig"}, [Supplementary Table 2](#S1){ref-type="supplementary-material"}). The wild-type grew with a maximum specific growth rate of 0.31--0.33 1/h under three conditions and with a maximum specific growth rate of 0.19--0.20 1/h at low pH or on galactose ([Supplementary Table 2](#S1){ref-type="supplementary-material"}). Under all five tested conditions, 13--15% of the investigated mutants exhibited a growth defect \>20% and up to six mutants did not grow at all under a given condition. The observed growth defects indicate that the deleted transcription factors were required under the respective growth condition.

Transcription factors that control the distribution of flux
-----------------------------------------------------------

To quantitatively evaluate the effect of single transcription factor deletions on pathway activity and thus on flux distributions, all strains were grown in 20% uniformly ^13^C-labeled glucose or galactose ([Supplementary Table 1](#S1){ref-type="supplementary-material"}). Both substrates enter central metabolism at the level of glucose-6-P, but they lead to primarily fermentative or respiro-fermentative metabolism, respectively ([@b4]; [@b27]). During fermentative metabolism, ATP is mainly produced through glycolysis with subsequent ethanol formation. During respiro-fermentative metabolism, ATP is simultaneously produced through glycolysis, the tricarboxylic acid (TCA) cycle and respiratory chain with only some formation of ethanol. As glucose and galactose are metabolized to an unequal extent through the alternative pathways of central carbon metabolism, different ^13^C-labeling patterns emerge that were subsequently determined in protein-bound amino acids by gas chromatography--mass spectrometry ([@b39]; [@b56]). From the determined mass isotopomer abundances in amino acids, we calculated six ratios of converging central metabolic fluxes ([@b2]; [@b56]), which determine the flux distribution in central carbon metabolism ([Figure 3](#f3){ref-type="fig"}, [Supplementary Figure 1](#S1){ref-type="supplementary-material"}, [Supplementary Table 1](#S1){ref-type="supplementary-material"}).

Depending on the growth condition, between 7 and 13% of the deleted transcription factors altered the determined flux ratios ([Figure 3](#f3){ref-type="fig"}, [Supplementary Table 3](#S1){ref-type="supplementary-material"}). Three out of six flux ratios corresponding to gluconeogenesis, glycine production through C1 metabolism and transport of mitochondrial oxaloacetate into the cytosol were never significantly altered in any of the mutants. Thus, these three flux ratios were not controlled by the investigated transcription factors under the tested conditions. The other three potentially transcriptionally controlled flux ratios were the upper bound of 'serine originating from the pentose phosphate pathway\', which quantifies the relative contribution of glycolysis versus the pentose phosphate pathway; 'serine originating from glycine\', which quantifies the relative contribution of the backward flux from glycine to serine versus the forward flux from 3-phospho-glycerate to serine; and 'mitochondrial oxaloacetate derived through anaplerosis\', which quantifies the relative contribution of the respiratory TCA cycle flux versus the replenishment of the biosynthetic precursor. The relative pathway usage of glycolysis and pentose phosphate pathway was altered only in three mutants, whereas the other two flux ratios were altered depending on the growth condition in 1--12% of the transcription factor mutants.

To exclude that the observed alterations in the flux distributions were indirect consequences of altered mutant physiology, we correlated the specific growth rates with the flux ratios by calculating the correlation factor between both (data not shown). If the transcription factors have an indirect effect on flux distributions via reduced growth rates in the deletion mutants, we expect a correlation between mutant growth rates and the determined flux distributions. For transcription factors with a direct effect on metabolism, we expect no such correlation. Relative pathway activity, for the flux distribution between glycolysis and the pentose phosphate pathway, and the convergent ratio of anaplerosis and TCA cycle were not correlated with growth rate (correlation coefficients considering all growth conditions of −0.27 and 0.19, respectively). Thus, they were directly controlled by the deleted transcription factors and not indirectly influenced through altered growth rate. The flux ratio quantifying the backward flux to serine, however, correlated with growth rate (correlation coefficient considering all growth conditions of −0.65), implying that the observed alterations in this flux ratio were indirect consequences of altered growth. As the results were obtained from single experiments in a screening setup, at least triplicate experiments were carried out for all transcription factor deletion mutants with altered flux ratios for the relative pathway activity between glycolysis and the pentose phosphate pathway, and the convergent ratio of anaplerosis and the TCA cycle ([Supplementary Table 4](#S1){ref-type="supplementary-material"}). Thereby, 23 out of the 24 originally identified mutants were reconfirmed.

As fluxes and their distribution are a readout for the functional metabolic consequences of a transcript alteration, we conclude that 23 transcription factors control flux distributions under at least one of the tested growth conditions, leading to 42 condition-dependent interactions of transcription factors with metabolic pathway activity. All 23 transcription factors controlled the TCA cycle flux activity. Two of them (Rtg1/3) also controlled the relative activity between glycolysis and the pentose phosphate pathway. Thus, transcriptional control focussed almost exclusively on the TCA cycle and probably also on the functionally connected, but here not observed, respiratory chain, while the remainder of central carbon metabolism was not affected. The control of the TCA cycle flux activity through the 23 identified transcription factors exhibited different magnitudes of alteration ([Figure 4](#f4){ref-type="fig"}): during growth on galactose, the deletion of seven transcription factors led to a completely abolished TCA cycle usage, but none of the deletion mutants with higher relative flux through the TCA cycle actually achieved a TCA cycle flux comparable with that observed on fully respiratory carbon sources (e.g., on pyruvate or ethanol; [@b11]).

How many transcription factors could have been predicted to affect pathway activity based on their target gene patterns? The Yeastract database lists 71 of the investigated transcription factors with at least one target gene in central metabolism on the basis of literature-curated, direct, indirect or undefined evidence from expression and DNA binding data, which could thus potentially affect pathway activity. Although 55 transcription factors have at least one target in glycolysis or the pentose phosphate pathway, the flux distribution between those two pathways was altered in only two mutants. Of the 35 transcription factors with at least one target in the TCA cycle, in contrast, 23 exerted control under at least one of the tested conditions. To assess the significance of this seemingly better predictive fidelity, we calculated the predictive fidelity of expression and DNA binding data for all TCA cycle genes by considering (i) only direct or (ii) direct, indirect and undefined evidence. While generally predictive fidelity increased with the number of transcription factor target genes in the TCA cycle, there was no particular combination that achieved a high percentage of true-positive predictions at a low false-negative percentage ([Figure 5](#f5){ref-type="fig"}, [Supplementary Table 5](#S1){ref-type="supplementary-material"}). Most relevant for a first prediction on potential flux control, where a low false-negative rate is desired, was the combination of all three lines of evidence for transcription factors with one or more target genes in the TCA cycle genes; (26.1% false negatives and 48.6% true positives). Thus, the prediction of flux controlling transcriptional events on the basis of expression and DNA binding data is rather limited for the TCA cycle and not possible for others like the pentose phosphate pathway.

In principle, the low predictive power of gene regulation data for functional flux responses could be caused by transcription factor redundancy. To test this hypothesis, we obtained ^13^C-flux data from the double and triple transcriptional factor mutants Nrg1/2, Msn2/4 and Mig1/2/3 (data not shown). We decided to test these mutants as the deleted transcription factors are main regulators of glucose repression and stress responds ([@b55]). Yet, even these multiple deletions did not result in altered TCA cycle flux distributions, indicating that redundancy is not the primary reason for the observed robustness.

Relevant TCA cycle enzymes that enable higher pathway usage
-----------------------------------------------------------

Of the 23 transcription factors that controlled TCA cycle flux distributions under the tested conditions, only Bas1, Gcn4, Gcr2 and Pho2 exerted control under more than one condition ([Figure 4](#f4){ref-type="fig"}). None of these four transcription factors had previously been identified as a key regulator of the TCA cycle. While Gcn4, Gcr2 and Pho2 have known targets in the TCA cycle, our finding is entirely novel for Bas1. Gcn4 is a global regulator of amino-acid biosynthesis and also has five known targets in the TCA cycle (*LPD1*, *CIT3*, *ACO2*, *IDH1*, *IDP1*) ([@b22]; [@b47]). Bas1 and Pho2 act together to activate purine and histidine biosynthesis, and only Pho2 has the TCA cycle gene *IDH1* as a target ([@b16]; [@b44]; [@b47]). Gcr2 is an activator of glycolysis genes, but six TCA cycle genes are also among its known targets (*CIT1*, *CIT3*, *ACO1*, *SDH2*, *SDH3*, *SDH4*) ([@b5]; [@b47]). For these four mutants we asked which enzymes are relevant for the higher activity of the TCA cycle.

For this purpose, we determined the abundance of 50 central metabolic enzymes with targeted proteomics in the four mutants during growth on glucose ([Figure 6](#f6){ref-type="fig"}, [Supplementary Table 6](#S1){ref-type="supplementary-material"}). In general, glycolytic enzyme abundances were decreased in the *GCR2* mutant as expected from the known function of Gcr2, as an activator of glycolysis ([@b5]). The *GCN4* deletion hardly altered any enzyme abundances, except those of TCA cycle enzymes. The *BAS1* and *PHO2* mutants exhibited very similar patterns of differentially expressed enzymes; that is, all 11 enzyme alterations observed in the *PHO2* mutant were also found in the *BAS1* mutant, supporting the view that they act together ([@b16]; [@b44]). The consistent increase of several glycolysis enzymes in these two mutants, however, did not lead to an alteration in the relative use of glycolysis and the pentose phosphate pathway.

Consistently, increased TCA cycle enzyme abundances in all four mutants was only found for citrate synthase (Cit1) and malate dehydrogenase (Mdh1) ([Figure 6](#f6){ref-type="fig"}, [Supplementary Table 6](#S1){ref-type="supplementary-material"}). This suggests that the increase in abundance of these two enzymes is necessary to enable the observed higher activity of the TCA cycle. As the *BAS1* and *GCR2* mutants displayed the highest TCA cycle activity, we looked for enzymes that were more abundant in these two strains, a criterion that was only fulfilled by isocitrate dehydrogenase (Idh1). In addition, the Idh2 member of the isocitrate dehydrogenase complex was more abundant, but the *P*-value for the *GCR2* mutant was 0.08, a value greater than the chosen cutoff *P*-value of 0.05. Thus, we concluded that during growth on glucose, increased abundance of Cit1 and Mdh1 is necessary to increase the TCA cycle flux from 0 to 0.01--0.03 mmol/g/h. The additional further flux increase to 0.10--0.13 mmol/g/h then requires an additional increase in abundance of Idh1/2p; as seen in the *BAS1* and *GCR2* mutants. Although these enzymes are apparently necessary for achieving a higher TCA cycle activity, they are not sufficient as additional components of the respiratory chain must also be expressed at higher levels.

Signaling cascades leading to the control of TCA cycle activity
---------------------------------------------------------------

After identifying relevant enzyme targets for the higher TCA cycle flux, we asked through which signaling cascades Bas1, Gcr2, Gcn4 and Pho2 governed this change in activity. For this purpose we determined genome-wide transcript abundances in the four mutants during growth on glucose. Generally, expression of many genes was altered in all four mutants, including most of the known targets of the four transcription factors ([Figure 6](#f6){ref-type="fig"}, [Supplementary Table 7](#S1){ref-type="supplementary-material"}). As already observed for enzyme abundance alterations, the pattern of differentially expressed genes in the *BAS1* and *PHO2* mutants was very similar, strongly supporting the view that they act together. When comparing protein and transcript abundance alterations in central carbon metabolism, the magnitude of transcript abundance alterations was about half of the abundance alterations in the corresponding enzymes, yet the direction was always consistent ([Figure 6](#f6){ref-type="fig"}).

To identify active signaling cascades leading to the control of TCA cycle activity in the four mutants, we predicted differentially activated transcription factors based on the activity pattern of their target genes ([@b34]). The underlying hypothesis is that a transcription factor is potentially differentially activated in the mutant compared with the wild type when its target genes are differentially expressed. Based on all increased transcripts, that were identified as potentially relevant for the higher TCA cycle flux, we found 47, 53, 31 and 14 transcription factors to be differentially activated in the *BAS1*, *GCN4*, *GCR2* and *PHO2* mutants, respectively ([Supplementary Table 8](#S1){ref-type="supplementary-material"}). Not unexpectedly due to the chosen set of investigated transcription factor mutants, the majority of these differentially activated transcription factors were related to metabolism or stress response.

The inferred pattern of differentially activated transcription factors suggests reduced glucose repression in all four mutants ([Table I](#t1){ref-type="table"}). For the *GCR2* mutant, our conclusion is based only on the differential activity of Nrg1, a key transcription factor for maintaining glucose repression ([@b58]), whereas for the *PHO2* mutant it is based on differential activity of the Hap-complex, a global regulator of respiration and a target of glucose repression ([@b55]; [@b49]). The evidence is stronger for the *BAS1* mutant because both Nrg1 and the Hap-complex appear to be differentially activated. In addition, Adr1, a target of glucose repression through its activating kinase Snf1 ([@b55]), was identified as differentially activated. For the *GCN4* mutant we have the strongest evidence, as all differentially activated transcription factors described for the other three mutants are also found in *GCN4* mutant. Moreover, we also found Mig1, the major transcription factor of the Snf1 repressor complex involved in glucose repression ([@b49]), and Msn2/4 to be differentially activated. Differential activity of Msn2/4, based on the upregulation of its target genes in the *GCN4* mutant, indicates less strong signaling of PKA ([@b55]), which is one of the two major downstream regulators of glucose repression. Most of the identified differentially activated transcription factors were also tested as single deletions in the primary screen, but did not lead to flux alterations.

To validate the above hypotheses on glucose repression-related regulation events, we focussed on the *GCN4* mutant. The *GCN4* mutant has potentially reduced PKA activity, which leads to increased Snf1 activity ([@b18]; [@b20]; [@b42]). This in turn leads to the activation of the Hap-complex and its targets ([@b40]; [@b55]), resulting in an increased TCA cycle activity ([Figure 7](#f7){ref-type="fig"}). Hence, hyperactivation of PKA should restore TCA cycle activity to wild type levels. Deletion of *BCY1* is one possibility to uncouple PKA activity from upstream signals, leading to constitutively active PKA ([@b55]). We constructed the *BCY1* deletion strain in the *GCN4* mutant background, but the double mutant grew very poorly. Nevertheless, the determined TCA cycle activity in cultures that grew to sufficient density was indistinguishable from the activity in wild-type cells, suggesting that the *GCN4* mutant phenotype is a result of reduced PKA activity ([Table II](#t2){ref-type="table"}). Thus, we expected increased Snf1 activity in the *GCN4* mutant. Deletion of *SNF1* in the *GCN4* mutant background reduced TCA cycle activity, but did not fully restore wild-type levels ([Table II](#t2){ref-type="table"}). These results suggest that although Snf1 activity was higher in the *GCN4* mutant, increased Snf1 activity accounted only partially for the observed phenotypes. Hence, PKA regulates TCA cycle activity, at least in part, through a Snf1p-independent mechanism ([Figure 7](#f7){ref-type="fig"}). Finally, simultaneous deletion of *GCN4* and *HAP4* restored TCA cycle activity to levels and *HAP4* overexpression in wild-type significantly increased TCA activity to levels comparable with the *GCN4* mutant ([Table II](#t2){ref-type="table"}). This confirms that the Hap-complex is of crucial importance for Gcn4-dependent regulation of TCA cycle flux. Thus, the *GCN4* mutant phenotype of higher TCA cycle flux can be readily explained by decreased activity of PKA and increased activity of Snf1, which impinge on the Hap-complex to regulate flux through the TCA cycle ([Figure 7](#f7){ref-type="fig"}), thereby validating our hypothesis derived from the transcript data analysis. In the biological context, the observed positive feedback loops between PKA and Gcn4 might be advantageous for the cell, due to the interlinkage of the stress response triggered by the lack of amino acids and the substrate response triggered by the highly repressive carbon substrate glucose, as both processes are at least partially dependent on PKA.

Discussion
==========

Starting from the currently largest set of ^13^C-based flux distributions, we identified networks of individual transcription factors that control metabolic pathway activity. These networks of active metabolic control have the following properties. First, they are highly condition dependent, as at most four transcription factors control the same metabolic flux distribution under more than one growth conditions. Second, they focus almost exclusively on the TCA cycle, thereby controlling the switch between respiratory and fermentative metabolism, which is consistent with more limited transcription factor deletion studies in bacteria ([@b12]; [@b36]; [@b33]). Third, with four to 14 active transcription factors, they are small compared with gene regulation networks that were obtained from expression and DNA binding data.

One of the first large-scale studies to monitor genome-wide gene function with growth rate as a functional readout was performed by [@b14]. Compared with our results, they found more transcription factors that control cellular function, mainly because growth rate is a more general readout on function than metabolic fluxes, as essentially all cellular processes can affect growth rate. Corroborating our finding of a major discrepancy between the responsive gene regulatory network and the network that actively controls function under a given condition, [@b14] found that only 7% of the gene expression-based predicted phenotypes were indeed detected at the level of growth rate. Thus, cellular functions are relatively robust to altered gene expression during steady-state exponential growth.

For the metabolic network studied here, robustness is also apparent from the fact that upregulated TCA cycle fluxes were not sufficient to achieve full respiratory metabolism with absent or low ethanol formation. Several explanations could potentially explain the observed robustness. First, the results might be condition specific, for example, the chosen carbon substrates might require only a small set of transcription factors to control the flux distribution. Second, other regulation mechanisms such as post-transcriptional modifications might actually be the primary flux controlling elements ([@b21]). Third, the redundancy of transcriptional networks ([@b45]) might mask the effect of single transcription factor deletions. While we cannot entirely rule out transcription factor redundancy, none of the three tested double and triple transcription factor deletion mutants exhibited a noticeable TCA cycle flux impact; hence, argue against redundancy. Fourth, environmental signals might be transmitted by different signaling pathways to several transcription factors, whose orchestrated action on multiple target genes is necessary to achieve a functional flux response. This latter hypothesis would explain why several transcription factors exert flux effects on the same pathway, but each flux effect is relatively small, as further, coordinated manipulations would be necessary to further increase the respiratory flux. This idea is supported by the observation that combined disruption of two glucose signaling pathways shifts metabolism toward respiration, whereas the single signaling pathway disruptions had no effects ([@b29]). While likely several reasons contribute to the observed robustness, the fourth hypothesis appears to be the most probable one.

In contrast to the above robustness of fermentative metabolism, *S. cerevisiae* appears to have no back up for transcription factors that are critical to sustain respiration. During partly respiratory metabolism on galactose, we show that that single transcription factor deletions can essentially abolish the TCA cycle flux, and thus respiration. This fragility of respiration and the preferred fermentative mode of energy production suggest that yeast is a good model for the so-called Warburg effect in many human cancers ([@b50]). Thus, synthetic lethal screens ([@b7]) and large-scale yeast omics data combined with metabolic and hierarchical control analysis ([@b48]; [@b10]) or other modeling approaches have the potential to identify key mechanisms and potential drug targets that prevent this metabolic shift during cancer development. Beyond knowledge of regulatory network architecture, our findings demonstrate the importance of identifying and quantifying the extent to which regulatory effectors alter cellular function.

Materials and methods
=====================

Strains, medium and cultivation condition
-----------------------------------------

*S. cerevisiae* wild-type FY4 MATa ([@b51]) (kindly provided by Fred Winston) was used as wild type. The single deletion strains ([Supplementary Table 9](#S1){ref-type="supplementary-material"}) were constructed as whole gene deletion by using a *KanMX4* cassette in the prototroph background of FY4 MATa ([@b51]) (kindly provided by Charlie Boone), which is isogenic to the sequenced S288C strain. All double deletion strains were constructed by crossing the MATa and the MATalpha single deletion strains, except of the Δ*gcn4*Δ*bcy1* strain. This strain was constructed using a *NatMX4* cassette. For overexpression, we used the pRS41H plasmid ([@b46]) (kindly provided by Eckhard Boles). For overexpression of *HAP4*, a *RPS2 (promotor)--HAP4 (overexpressed gene)--CYC1 (terminator)* construct was cloned into the pRS41H plasmid.

Liquid cultivations were carried out in minimal medium batch cultures as described by [@b2] with 10 g/l glucose or galactose. Adjustments for environmental stress conditions: pH 3.75 was achieved with sulfuric acid (pH 3.75 condition), 0.8 mol/l sorbitol was added to the medium (0.8 M sorbitol condition), ammonium sulfate was substituted with the same amount (mol/mol) of urea (urea condition) and glucose was substituted with the same amount (g/g) of galactose (galactose condition). For the overexpression strain, 300 mg/l hygromycin B (Invitrogen, Basel, Switzerland) was added. Precultures were always grown in glucose minimal medium. Culture aliquots for transcript, enzyme and flux ratio analysis were always harvested during mid-exponential growth phase at an optical density at 600 (OD~600~) of OD~600~ 0.5--1.2 following a standardized growth curve.

FY4 was freshly plated from a glycerol stock on a YPD (1% (w/v) yeast extract, 2% (w/v) peptone and 2% (w/v) glucose) plate (2% agar), and the deletion strains were freshly plated from a glycerol stock on a YPD plate containing 300 μg/ml geneticin (G418) (Gibco, Paisley, UK). Liquid precultures were inoculated from YPD plates. Cultivations were performed in 500-ml shake flasks with a culture volume of 50 ml, at 30°C and 300 r.p.m. in a shaker with 50-mm shaking amplitude (proteome measurement), or in 96-deep-well plates ([@b9]) (Kuehner AG, Birsfeld, Switzerland) with a culture volume of 1.2 ml, at 30°C and 300 r.p.m. in a shaker with 50-mm shaking amplitude (transcriptome, flux ratio and physiology measurement). To improve mixing, a single 4-mm diameter glass bead (Sigma-Aldrich, Buchs, Switzerland) was added to each well.

Specific growth rates were determined from at least three independent cultures and at least six OD~600~ data points during the exponential growth phase per culture, measured with a spectra-photometer (Molecular Devices, Sunnyvale, USA).

The minimal medium for the flux experiments contained a mixture of 20% \[U-^13^C\]-labeled glucose (^13^C enrichment ⩾99%, Cambridge Isotope Laboratories, Andover, USA) or galactose (^13^C enrichment ⩾98%, Omnicron Biochemicals, South Bend, USA) and 80% naturally labeled glucose or galactose, respectively (or 100% \[C1-^13^C\]-labeled glucose (^13^C enrichment ⩾99%, Cambridge Isotope Laboratories)).

Flux ratio analysis
-------------------

Flux analysis was performed as described by [@b2]. ^13^C-labeled cultures (20% U-^13^C) were harvested during mid-exponential growth (OD~600~ 0.5--1.2). The cells were washed three times with ddH~2~O and stored at −20°C for a gas chromatography-mass spectrometry analysis. Samples for gas chromatography-mass spectrometry analysis were prepared as followed: the frozen cell pellet was hydrolyzed with 6 mol/l HCI for 12 h at 105°C. The samples were dried at 95 °C under a constant air stream. They were derivatized using 20 μl of the solvent DMF (Sigma-Aldrich) and 20 μl of the derivatization agent *N*-(*tert*-butyldimethylsilyl)-*N*-methyl-trifluoroacetamide with 1% *tert*-butyldimethylchlorosilane (Sigma-Aldrich) for 1 h at 85°C. The mass isotopomer distributions of the protein-bound amino acids were measured with a 6890N GC system (Agilent Technologies, Santa Clara, USA) combined with a 5973 Inert XL MS system (Agilent Technologies). Flux ratios were determined from the mass isotopomer distribution of the protein-bound amino acids with the software FiatFlux ([@b57]), using the analytical equations developed by [@b2]. For the '*mit* oxaloacetate from anaplerosis\' flux ratio, Equation (3) from [@b2], implemented in the software FiatFlux ([@b57]), was applied ([Supplementary Figure 2](#S1){ref-type="supplementary-material"}):

where 2-oxoglutarate~25~ is the C2--C5 fragment of 2-oxoglutarate; glc~1*U*~ is one carbon glucose fragments; glc~2*U*~ are two carbon glucose fragments.

Flux ratio significance cutoff was \>10%. The exceptions were '*mit* oxaloacetate from anaplerosis\' and 'P-enol-pyruvate from *cyt* oxaloacetate\', where a difference from the wild type \>5% was considered as significant, as technical accuracy for these ratios are very good (1.6% instead of \>3.0%).

Transcriptome data
------------------

For transcriptome analysis, harvesting, extraction and DNase digestion of mRNA aliquotes were performed by the mechanical disruption protocol of the RNAesy Mini Kit (50) (Qiagen, Rapperswil, Switzerland). RNA samples were reverse-transcribed into double-stranded cDNA with One-Cycle cDNA Synthesis Kit (Affymetrix Inc., P/N 900431, Santa Clara, CA). The double-stranded cDNA was purified using a Sample Cleanup Module (Affymetrix Inc., P/N 900371). The purified double-stranded cDNA was *in vitro* transcribed in the presence of biotin-labeled nucleotides using a IVT Labeling Kit (Affymetrix Inc., P/N 900449). The biotinylated cRNA was purified using a Sample Cleanup Module (Affymetrix Inc., P/N 900371), and its quality and quantity were determined using NanoDrop ND 1000 and Bioanalyzer 2100, respectively. Biotin-labeled cRNA samples were fragmented randomly to 35--200 bp at 94°C in fragmentation buffer (Affymetrix Inc., P/N 900371) and were suspended in 100 μl of hybridization mix (Affymetrix Inc., P/N 900720) containing a hybridization control and control oligonucleotide B2 (Affymetrix Inc., P/N 900454). Samples were hybridized to GeneChip Yeast Genome 2.0 arrays for 16 h at 45°C. Arrays were then washed using an Affymetrix Fluidics Station 450 FS450 0003 protocol. An Affymetrix GeneChip Scanner 3000 (Affymetrix Inc.) was used to determine the fluorescent intensity emitted by the labeled target. Raw data are stored in GEO (GSE19569, and GSE24057).

Proteome data
-------------

For proteome analysis, the targeted proteomics protocol as described by [@b38], [@b37]) was applied. Cultures were harvested at mid-exponential growth and washed twice with 4°C cold washing buffer (20 mmol/l Hepes, 2 mmol/l EDTA, pH 7.5). The samples were shock-frozen in liquid nitrogen and stored at −80°C. Cell pellets were disrupted mechanically by vortexing in the presence of glass beads, and proteins were precipitated with −20°C cold acetone. The protein concentration was determined with a Bradford assay (Biorad, Munich, Germany). Fifty μg proteins were mixed with 50 μg 100% \[^15^N\]-labeled protein as internal standard ([@b37]). Sulfur bridges were reduced with dithiothreitol, blocked with iodoacetamide and proteins were digested with trypsin (Promega, Madison, USA) (1 μg trypsin per 100 μg protein). The resulting peptides were cleaned with a Sep-Pak tC18 (50 mg) reverse-phase cartridge (Waters, Milford, USA). The desalting solution was 0.1% (v/v) formic acid water mixture, and the peptides were eluted from the cartridge with 80% (v/v) acetonitrile water mixture. They were dried under vacuum and resuspended in 0.1% formic acid. Proteins were quantified on a nano-LC-MS/MS system consisting of a Tempo nano LC system (Applied Biosystems, Foster City, USA) and a 4000Qtrap (MSD---Sciex, Applied Biosystems), operated in MS/MS mode. Raw tandem mass spectrometry data have been deposited in the publicly accessible repository of proteomics data PeptideAtlas ([www.mrmatlas.org](http://www.mrmatlas.org), [@b38]), and can be browsed using the yeast genome database ([@b6]) accession names.

Statistical analysis
--------------------

For transcriptome analysis, the Affymetrix CEL files were processed using R (version 2.8.0; <http://www.r-project.org/>) and the Bioconductor affy package ([@b13]). Probe intensities were normalized for background by using the robust multiarray average method ([@b25]), using only perfect match probes. Normalization was performed using the qsplines algorithm ([@b52]). Gene expression values were calculated using the [@b31]) expression index calculation method. The *P*-values for proteome analysis were calculated with a two-tailed heteroscedastic Student\'s *t*-test. Predictive fidelity was calculated based on binding and expression data from the Yeastract database ([@b47]), thereby a transcription factor was counted as potentially flux distribution controlling when it had a target in a certain pathway. For assessing the predictive fidelity, we calculated true-positive predictions (transcription factor that controls flux and has x target gene in the controlled pathway) and false-negative predictions (transcription factor that controls flux but had less than x target gene in the controlled pathway). We varied x between one and the number of target genes that were necessary to achieve 100% true-positive predictions. For prediction of differentially activated transcription factors, the differential gene expression for pairwise comparisons (mutant versus wild type) was assessed using a two-tailed heteroscedastic Student\'s *t*-test. The activity of a transcription factor was assessed by using the scoring system described in [@b34]. The transcriptional regulatory network derived from Yeastract database ([@b47]) (documented direct only; 20/01/2008) was used as topology for transcription factor---gene interactions. Gene nodes were scored with *P*-values, whereas information on fold change was used to determine up- or downregulated subnetwork topologies. A transcription factor with *z*-score ⩾2 is considered to have significantly changed activity.
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![Schematic overview on the performed experiments and data analysis. Yellow ellipses and squares indicate altered protein and gene expression in transcription factor mutants compared with the wild type, respectively. Black ellipses and squares indicate no difference between mutant and wild type.](msb201091-f1){#f1}

![Maximum-specific growth rates of the 119 transcription factor mutants under five growth conditions. Four replicates of the wild type are depicted as black dots. Deletion strains are depicted as blue dots (average of four replicates) ([Supplementary Table 2](#S1){ref-type="supplementary-material"}).](msb201091-f2){#f2}

![Intracellular ratios of converging fluxes in 119 transcription factor mutants under five growth conditions during steady state. Flux ratios were calculated from uniformly ^13^C-labeled glucose or galactose experiments. The wild type is depicted as black dots (four replicates) and the deletion strains as blue dots (single measurements) ([Supplementary Table 3](#S1){ref-type="supplementary-material"}). Blue metabolites and arrows in the drawing of central carbon metabolism indicate network nodes, for which flux ratios were determined. Capitalized metabolites are extracellular substrates or products. Pathways are depicted in italic.](msb201091-f3){#f3}

![Network of transcription factors that controls TCA cycle flux during steady-state growth in batch cultures grown either on glucose or galactose ([Supplementary Table 4](#S1){ref-type="supplementary-material"}). Line thickness indicates the magnitude of difference to the wild type.](msb201091-f4){#f4}

![Predictive fidelity of expression and binding data ([@b47]) for transcription factors that control metabolic fluxes.](msb201091-f5){#f5}

![Differentially expressed transcripts and enzymes of *BAS1*, *GCN4*, *GCR2* and *PHO2* transcription factor mutants during exponential growth on glucose (fold change ⩾1.3, *P*-value ⩽0.05). 'ND\' stands for not determined.](msb201091-f6){#f6}

![Signaling cascades involving Gcn4. Known signaling cascade involving Gcn4 ([@b40]; [@b42]; [@b55]) and the here revealed Gcn4 signaling cascade of TCA cycle gene expression.](msb201091-f7){#f7}

###### Potentially differentially activated transcription factors that indicate a reduced glucose repression in the four mutants compared with the wild type

  Strains   Differentially activated transcription factors
  --------- ------------------------------------------------
  Δ*gcr2*   Nrg1
  Δ*pho2*   Hap-complex
  Δ*bas1*   Adr1, Hap-complex, Nrg1
  Δ*gcn4*   Adr1, Hap-complex, Mig1, Msn2/4, Nrg1

###### Relative TCA cycle flux to mitochondrial oxaloacetate in double deletion strains and *HAP4* overexpression strains

  Strains                                                                                                                                                                                                                                                                                                                                        Relative TCA cycle flux   
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------- ------
  Wild type                                                                                                                                                                                                                                                                                                                                      0.00                      0.01
  Δ*gcn4*                                                                                                                                                                                                                                                                                                                                        0.13                      0.03
  Δ*gcn4*Δ*bcy1*                                                                                                                                                                                                                                                                                                                                 0.01                      ND
  Δ*gcn4*Δ*snf1*                                                                                                                                                                                                                                                                                                                                 0.05                      0.01
  Δ*gcn4*Δ*hap4*                                                                                                                                                                                                                                                                                                                                 0.01                      0.02
                                                                                                                                                                                                                                                                                                                                                                            
  Wild type with empty plasmid                                                                                                                                                                                                                                                                                                                   0.01                      0.00
  Wild type with *RPS2-HAP4*                                                                                                                                                                                                                                                                                                                     0.13                      0.01
  Values are determined with ^13^C-flux analysis as one minus ratio 'mitochondrial oxaloacetate derived through anaplerosis\' ([@b2]) ([Supplementary Figure 1](#S1){ref-type="supplementary-material"}, [Supplementary Table 1](#S1){ref-type="supplementary-material"}). Error ranges were calculated from at least two independent samples.                             
  'ND\' stands for not determined.                                                                                                                                                                                                                                                                                                                                         
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